Our most pressing research questions pertain to understanding the regulatory landscape of alternative meat products.
We’re interested in your views on the following questions.
How much time does it take to obtain FDA approval for a cell-based meat alternative?
How does the regulatory landscape vary between following regions: USA, Europe, Middle East, Asia, East Asia – and what regulatory procedure would be best for XPRIZE to follow?
How long is the process of labelling a product (approximately)?
Is the end-product what regulatory bodies focus on evaluating or are they evaluating the process in which the product is made at various stages? Does this differ across geographies, and if so, which regulatory group is gold standard? If so, why or why not?
We’d appreciate any insights you’re able to provide. The more specific, the better!